Institut für Virologie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Retrovirology. 2011 Aug 15;8:66. doi: 10.1186/1742-4690-8-66.
Foamy viruses (FVs) unlike orthoretroviruses express Pol as a separate precursor protein and not as a Gag-Pol fusion protein. A unique packaging strategy, involving recognition of briding viral RNA by both Pol precursor and Gag as well as potential Gag-Pol protein interactions, ensures Pol particle encapsidation.
Several Prototype FV (PFV) Gag-Pol fusion protein constructs were generated to examine whether PFV replication is compatible with an orthoretroviral-like Pol expression. During their analysis, non-particle-associated secreted Pol precursor protein was discovered in extracellular wild type PFV particle preparations of different origin, copurifying in simple virion enrichment protocols. Different analysis methods suggest that extracellular wild type PFV particles contain predominantly mature p85(PR-RT) and p40(IN) Pol subunits. Characterization of various PFV Gag-Pol fusion constructs revealed that PFV Pol expression in an orthoretroviral manner is compatible with PFV replication as long as a proteolytic processing between Gag and Pol proteins is possible. PFV Gag-Pol translation by a HIV-1 like ribosomal frameshift signal resulted in production of replication-competent virions, although cell- and particle-associated Pol levels were reduced in comparison to wild type. In-frame fusion of PFV Gag and Pol ORFs led to increased cellular Pol levels, but particle incorporation was only marginally elevated. Unlike that reported for similar orthoretroviral constructs, a full-length in-frame PFV Gag-Pol fusion construct showed wildtype-like particle release and infectivity characteristics. In contrast, in-frame PFV Gag-Pol fusion with C-terminal Gag ORF truncations or non-removable Gag peptide addition to Pol displayed wildtype particle release, but reduced particle infectivity. PFV Gag-Pol precursor fusion proteins with inactivated protease were highly deficient in regular particle release, although coexpression of p71(Gag) resulted in a significant copackaging of these proteins.
Non-particle associated PFV Pol appears to be naturally released from infected cells by a yet unknown mechanism. The absence of particle-associated Pol precursor suggests its rapid processing upon particle incorporation. Analysis of different PFV Gag-Pol fusion constructs demonstrates that orthoretroviral-like Pol expression is compatible with FV replication in principal as long as fusion protein processing is possible. Furthermore, unlike orthoretroviruses, PFV particle release and infectivity tolerate larger differences in relative cellular Gag/Pol levels.
与正逆转录病毒不同,泡沫病毒(FV)将 Pol 表达为单独的前体蛋白,而不是 Gag-Pol 融合蛋白。独特的包装策略,涉及到前体 Pol 和 Gag 对 bridged 病毒 RNA 的识别,以及潜在的 Gag-Pol 蛋白相互作用,确保了 Pol 颗粒的包裹。
生成了几种原型 FV(PFV)Gag-Pol 融合蛋白构建体,以研究 PFV 复制是否与正逆转录病毒样 Pol 表达兼容。在分析过程中,在不同来源的野生型 PFV 粒子制剂的非粒子相关的分泌前体 Pol 蛋白被发现,在简单的病毒粒子富集方案中共同纯化。不同的分析方法表明,细胞外野生型 PFV 粒子主要包含成熟的 p85(PR-RT)和 p40(IN) Pol 亚基。对各种 PFV Gag-Pol 融合构建体的表征表明,只要 Gag 和 Pol 蛋白之间的蛋白水解加工是可能的,以正逆转录病毒方式表达 PFV Pol 与 PFV 复制兼容。通过 HIV-1 样核糖体移码信号进行的 PFV Gag-Pol 翻译导致产生了复制有活性的病毒粒子,尽管与野生型相比,细胞和粒子相关的 Pol 水平降低了。PFV Gag 和 Pol ORFs 的框内融合导致细胞内 Pol 水平升高,但粒子掺入仅略有升高。与类似的正逆转录病毒构建体报告的情况不同,全长框内 PFV Gag-Pol 融合构建体显示出与野生型样粒子释放和感染性特征。相比之下,带有 C 末端 Gag ORF 截断或不可去除的 Gag 肽添加到 Pol 的框内 PFV Gag-Pol 融合显示出野生型粒子释放,但粒子感染性降低。具有失活蛋白酶的 PFV Gag-Pol 前体融合蛋白在常规粒子释放中高度缺乏,但共表达 p71(Gag)导致这些蛋白的显著共包装。
非粒子相关的 PFV Pol 似乎通过未知机制从受感染细胞中自然释放。缺乏粒子相关的 Pol 前体表明其在粒子掺入后迅速加工。对不同 PFV Gag-Pol 融合构建体的分析表明,只要融合蛋白加工是可能的,正逆转录病毒样 Pol 表达与 FV 复制在原理上是兼容的。此外,与正逆转录病毒不同,PFV 粒子释放和感染性可以容忍细胞内 Gag/Pol 水平相对差异较大。